European Neuropsychopharmacology

Print ISSN
0924-977X
Electronic ISSN
1873-7862
Impact factor
4.201
Publisher
Sciencedirect
URL
http://www.sciencedirect.com/science/journal/0924977X
Usage rank
2775
Article count
1650
Free count
6
Free percentage
0.00363636
PDFs via platforms
Sciencedirect, Gale, Ingenta, CSA, Rcgp, and Proquest

  1. Contents
    Author(s) unavailable

    European Neuropsychopharmacology 25(10):OBC (2015)

  2. Contents continued
    Author(s) unavailable

    European Neuropsychopharmacology 25(10):V (2015)

  3. ECNP Calendar of Events
    Author(s) unavailable

    European Neuropsychopharmacology 25(10):I (2015)

  4. Editorial Board
    Author(s) unavailable

    European Neuropsychopharmacology 25(10):IFC (2015)

  5. Editorial Board
    Author(s) unavailable

    European Neuropsychopharmacology 25(9):IFC (2015)

  6. P.1.i.055 Generalized anxiety disorder is characterised by a non-discriminative response of the ventromedial prefrontal cortex during fear learning

    European Neuropsychopharmacology 25:S331 (2015)

  7. P.1.j.008 The relationship between cognitive impairment and depression, anxiety and virological response in hepatitis C patients in Egypt

    European Neuropsychopharmacology 25:S337 (2015)

  8. P.1.j.006 New neurocognitive endophenotype for major depressive episode: the role of working memory and implicit learning in the acute phase of depression

    European Neuropsychopharmacology 25:S335 (2015)

  9. P.1.j.014 Effects of gallic acid and quercetin on learning and memory processes in young/healthy rats

    European Neuropsychopharmacology 25:S340 (2015)

  10. P.1.i.051 Intermittent Theta Burst Stimulation of the left dorsolateral prefrontal cortex for the treatment of persistent negative symptoms in schizophrenia

    European Neuropsychopharmacology 25:S329 (2015)

  11. P.1.j.009 Awareness of driving impairment: lapses versus excursions out-of-lane during highway driving

    European Neuropsychopharmacology 25:S337 (2015)

  12. P.1.j.005 Facial emotion recognition among siblings discordant for schizophrenia

    European Neuropsychopharmacology 25:S335 (2015)

  13. P.1.j.015 IQ differences among relatives of schizophrenia patients: a comparative study

    European Neuropsychopharmacology 25:S341 (2015)

  14. P.1.j.016 Impact of smoking on cognitive functions

    European Neuropsychopharmacology 25:S342 (2015)

  15. P.1.j.038 Post-synaptic proteins and apolipoprotein E-mediated risk of Alzheimer's disease

    European Neuropsychopharmacology 25:S354 (2015)

  16. P.1.k.023 The prevalence and impact on insomnia of periodic limb movements during sleep in the Korean elderly

    European Neuropsychopharmacology 25:S366 (2015)

  17. P.1.k.029 Predictors of acute psychiatry hospitalisation from a home treatment team

    European Neuropsychopharmacology 25:S369 (2015)

  18. P.1.j.030 Are schizophrenia patients worse performers of dual-tasking? Insights from motor timing

    European Neuropsychopharmacology 25:S349 (2015)

  19. P.1.k.032 The Suicide Ideation and Behavior Assessment Tool: development of a novel measure of suicidal ideation and behavior and perceived risk of suicide

    European Neuropsychopharmacology 25:S371 (2015)

  20. P.1.j.036 Comparison of spatial processing in schizophrenia and bipolar disorder

    European Neuropsychopharmacology 25:S353 (2015)